Episode
Achieving Longevity Escape Velocity with patient avatars — Martin Borch Jensen, CSO of Gordian Biotechnology
- Podcast
- Free Radicals
- Published
- Feb 17, 2026
- Duration seconds
- 6281
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/free-radicals-7588534/episodes/achieving-longevity-escape-velocity-with-patient-avatars-martin-borch-jensen-cso-of-gordian-biotechnology/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/free-radicals-7588534/achieving-longevity-escape-velocity-with-patient-avatars-martin-borch-jensen-cso-of-gordian-biotechnology.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Martin Borch Jensen is a scientist, entrepreneur and longevity advocate. He is the co-founder and CSO of Gordian Biotechnology, a company whose platform enables the simultaneous delivery and testing of hundreds of therapeutics in individual animals. They have raised over $60M from top investors like Founders Fund, Horizons Ventures, Fifty Years and the Longevity Fund. They also recently announced a partnership with Pfizer to apply Gordian’s proprietary mosaic screening platform to accelerate the discovery of therapeutic targets for obesity. Martin is also a prominent voice in the longevity community and activist. As founder and president of Norn Group, a do tank for longevity, he launched the Impetus Grants program, which has deployed roughly $34 million to scientists across 145 projects, with funding decisions made within 3 weeks to enable speed. In our conversation today, we cover the state of the longevity field, its major bottlenecks, theories of aging, the role of AI in longevity, and much more.